Wednesday, July 22, 2020 9:05:03 PM
Gcan has proven not to be of any value. If there were any value to gcan the symtomax people would be buying every share they could get their hands on. They don't seem to be very impressed with the product or its sales based on O demand for gcan stock. Now carry on with pipe dreams and calling Luke.
Recent GCAN News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:22:05 PM
- GCANRx Announces Relisting To OTCQB Market Tier • GlobeNewswire Inc. • 12/03/2025 12:45:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/16/2025 03:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2025 11:00:32 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 02:05:11 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/08/2025 01:56:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 03:57:40 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 05/06/2025 12:54:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/05/2025 10:09:45 AM
